ResMed holds Coefficient Of Variation of 263.40 and Risk Adjusted Performance of 0.41. Compared with Fundamental Indicators, Macroaxis technical analysis interface allows you to check existing technical drivers of ResMed as well as the relationship between them. In other words you can use this information to find out if the company will indeed mirror its model of past market data or the prices will eventually revert. We found nineteen technical drivers for ResMed which can be compared to its competitors. Please check ResMedInformation Ratio, Value At Risk as well as the relationship between Value At Risk and Expected Short fall to decide if ResMed is priced some-what accurately providing market reflects its current price of 100.93 per share. Given that ResMed has Jensen Alpha of 0.60, we recommend you check out ResMed recent market performance to make sure the company can sustain itself at future point.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of ResMed volatility. High ATR values indicate high volatility, and low values indicate low volatility. View also all equity analysis or get more info about average true range volatility indicators indicator.
ResMed Trend Analysis
Use this graph to draw trend lines for ResMed. You can use it to identify possible trend reversals for ResMed as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual ResMed price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.
ResMed Best Fit Change Line
The following chart estimates an ordinary least squares regression model for ResMed applied against its price change over selected period. The best fit line has a slop of 0.52 % which may imply that the returns on investment in ResMed will continue to fail. It has 34 observation points and a regression sum of squares at 220.44, which is the sum of squared deviations for the predicted ResMed price change compared to its average price change.
Diversify with ResMed
Build Optimal Portfolios
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add ResMed to your portfolio
Additionally take a look at Your Equity Center. Please also try Idea Breakdown module to analyze constituents of all macroaxis ideas. macroaxis investment ideas are predefined, sector-focused investing themes.